More

    Sutro Biopharma Presents Data from Dose-Optimization Portion of REFRαME-O1 Trial in Patients with Platinum Resistant Ovarian Cancer at SGO 2025

    Finance
    1



    [
    Sutro Biopharma Presents Data from Dose-Optimization Portion of REFRαME-O1 Trial in Patients with Platinum Resistant Ovarian Cancer at SGO 2025
    [og_img]
    https://www.investing.com/news/press-releases/sutro-biopharma-presents-data-from-doseoptimization-portion-of-refrimeo1-trial-in-patients-with-platinum-resistant-ovarian-cancer-at-sgo-2025-93CH-3930796


    Investing.com

    Montather Rassoul
    Montather Rassoulhttps://thefifthskill.com/

    Latest articles

    spot_imgspot_img
    Previous article
    ROSEN, A TOP RANKED LAW FIRM, Encourages Polestar Automotive Holding UK PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – PSNY
    Next article
    ROSEN, A TOP RANKED LAW FIRM, Encourages Newmont Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – NEM

    Related articles

    Leave a reply

    Please enter your comment!
    Please enter your name here

    spot_imgspot_img

    Popular articles

    Featured

    Newsletter

    Subscribe to get the latest news, offers and special announcements.

    By subscribing, you're accepting to receive promotions.

    © Copyright - Newspaper WordPress Theme by TagDiv